Author

Gabriela Tamariz

Institution: Alnylam Pharmaceuticals (United States)

Observed institution: Alnylam Pharmaceuticals (United States)

OpenAlex ID: A5097355349

Best Practices and Key Barriers for Amyloidosis Patient Care at US Specialized Amyloidosis Centers: An Analysis by ARC-ASPIRE

2026 · Jose Nativi-Nicolau, Johana Fajardo, et al. · Clinical Medicine Insights Cardiology

Best practices and key barriers for light chain (AL) amyloidosis patient care at US specialized amyloidosis centers: An analysis of ARC-ASPIRE.

2025 · Jose Nativi-Nicolau, Johana Fajardo, et al. · Journal of Clinical Oncology

Best Practices and Key Barriers for Amyloidosis Patient Care – a Representative Analysis of Multidisciplinary Amyloidosis Specialists, Referring Physicians, Patients, and Patient Advocacy Groups at US Specialized Amyloidosis Centers PC48 (#509)

2024 · Jose Nativi, Johana Fajardo, et al.

Works count: 3

Citation count:

H-index:

I10-index: